Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ANEBULO PHARMACEUTICALS INC (ANEB)

17 + Investors. Track Smart Money conviction in ANEB. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -3
Streak
1Q ▼
Buyers last Q
38%

Smart Money Signals — ANEB

Based on 17 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ANEB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 85% of 3.0Y peak

85% of all-time peak
17 funds currently hold this stock — 85% of the 3.0-year high of 20 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +13% more funds vs a year ago

fund count last 6Q
+2 new funds entered over the past year (+13% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🔴

Heavy selling pressure — only 38% buying

6 buying10 selling
Last quarter: 10 funds sold vs only 6 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.
⚠️

Fewer new buyers each quarter (-7 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 4 → 2 → 8 → 1. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

53% of holders stayed for 2+ years

53% conviction (2yr+) 24% medium 24% new
9 out of 17 hedge funds have held ANEB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Price up while funds trimmed (+65% value, -0% shares)

Value
+64%
Shares
+0%
Last quarter: total value of institutional ANEB holdings rose +65% even though funds reduced share count by 0%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.
➡️

Steady discovery — ~1 new funds/quarter

2 → 4 → 2 → 8 → 1 new funds/Q
New funds entering each quarter: 4 → 2 → 8 → 1. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 53% of holders stayed 2+ years

53% veterans 24% 1-2yr 24% new
Of 17 current holders: 9 (53%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 1% AUM from top-100

1% from top-100 AUM funds
8 of 17 holders rank in the top 100 by AUM, but together hold only 1% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ANEB

In 2025 Q4, 6 hedge funds were net buyers of ANEB (1 opened a new position, 5 added to an existing one), while 10 reduced or exited (6 trimmed, 4 sold completely) — a 38% buyer ratio, indicating net institutional distribution. Net fund flow last quarter: -3 funds (more exits than new entries). Total institutional holders: 17.

Hedge Fund Ownership: ANEB

How many hedge funds hold ANEB — quarterly history vs. share price
Quarterly hedge fund ownership of ANEB vs. share price

Market Analysis: ANEB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ANEB

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.3
/ 10
conviction
Hedge Fund Positioning: ANEB
2026 Q1 Stats Unlock in 9 days 17 + Investors

Track Smart Money conviction in ANEB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 17 20 -15.0%
13F Shares 22M 22M -0.05%
Total Value $92M $56M 64.84%
New Positions 1 8 -7
Increased Positions 5 4 +1
Closed Positions 4 6 -2
Reduced Positions 6 3 +3
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ANEB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

17 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ANEB. Verified SEC 13F-HR filings.

Top 13 institutional holders of ANEB — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 22NW, LP 35.68% 15,467,300 $84.8M
2 MANGROVE PARTNERS IM, LLC 0.21% 2,525,252 $2.6M
3 Nantahala Capital Management, LLC 0.10% 3,036,325 $3.1M
4 Rangeley Capital, LLC 0.04% 50,000 $50K
5 Ikarian Capital, LLC 0.00% 17,736 $18K
6 Tower Research Capital LLC (TRC) 0.00% 3,230 $3K
7 RENAISSANCE TECHNOLOGIES LLC 0.00% 25,098 $25K
8 MORGAN STANLEY 0.00% 399,404 $403K
9 CITADEL ADVISORS LLC 0.00% 24,239 $24K
10 BlackRock, Inc. 0.00% 23,790 $24K
11 UBS Group AG 0.00% 2,334 $2K
12 JPMORGAN CHASE & CO 0.00% 2,253 $2K
13 BANK OF AMERICA CORP /DE/ 0.00% 382
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ANEBULO PHARMACEUTICALS INC (ANEB)

What does the Smart Money Trend signal show for ANEB?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ANEB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ANEB?

Heavy selling pressure — only 38% buying: Last quarter: 10 funds sold vs only 6 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for ANEB holders?

Smaller funds dominant — 1% AUM from top-100: 8 of 17 holders rank in the top 100 by AUM, but together hold only 1% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ANEB?

53% of holders stayed for 2+ years: 9 out of 17 hedge funds have held ANEB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.